Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results

1mon ago, source: Business Insider

CHAPEL HILL, N.C., March 28, 2024 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a Phase 3, development-stage pharmaceutical company focused on ...

TENX: 2023 Financial Results

25d ago, source: Yahoo Finance

Tenax Therapeutics, Inc. (NASDAQ:TENX) reported full year 2023 results on March 28, 2024 in a press release and the filing of its Form 10-K with the SEC. Over the last five months, the company has ...

Tenax Therapeutics, Inc.

3y ago, source: CNN

Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26 ...

Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results

1mon ago, source: Stockhouse

CHAPEL HILL, N.C., March 28, 2024 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a Phase 3, development-stage pharmaceutical company focused on identifying, developing and ...

Tenax Therapeutics, Inc. Common Stock (TENX)

9y ago, source: Nasdaq

Get up to 10 years of daily historical stock prices & volumes. The "Close/Last" is the “adjust consolidated close price”. Data provided by Edgar Online. The net and percent change in the ...

Tenax Therapeutics Inc TENX

25d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results

1mon ago, source: ADVFN

Tenax Therapeutics, Inc. (Nasdaq: TENX), a Phase 3, development-stage pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and ...